moclobemide has been researched along with Body Weight in 6 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of chronic moclobemide administration on ethanol consumption, blood ethanol level, motor coordination and seizures induced by an audiogenic stimulus during ethanol withdrawal syndrome have been investigated in chronically ethanol intoxicated rats." | 3.69 | Investigation of the effects of moclobemide in chronic ethanol feeding rats. ( Ayhan, IH; Celik, T; Sever, B; Uzbay, IT, 1995) |
| "Data on a twice-daily dosage schedule with moclobemide in the treatment of depression is limited." | 2.67 | Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules. ( Bodemer, W; Gagiano, CA; Hart, GA; Schall, R, 1994) |
| " Adverse events during this long-term treatment were also compared with those of a subgroup of these patients who, before long-term treatment, were treated on a short-term basis (n = 706)." | 2.67 | Safety and efficacy during long-term treatment with moclobemide. ( Amrein, R; Moll, E; Neumann, N; Schmid-Burgk, W; Stabl, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, FU | 1 |
| Hösch, H | 1 |
| Seibert, H | 1 |
| Klug, R | 1 |
| Köppler, D | 1 |
| Jäger, M | 1 |
| Gagiano, CA | 1 |
| Hart, GA | 1 |
| Bodemer, W | 1 |
| Schall, R | 1 |
| Moll, E | 1 |
| Neumann, N | 1 |
| Schmid-Burgk, W | 1 |
| Stabl, M | 1 |
| Amrein, R | 1 |
| Uzbay, IT | 1 |
| Sever, B | 1 |
| Celik, T | 1 |
| Ayhan, IH | 1 |
| Bakish, D | 1 |
| Bradwejn, J | 1 |
| Nair, N | 1 |
| McClure, J | 1 |
| Remick, R | 1 |
| Bulger, L | 1 |
| Schläppi, B | 1 |
3 trials available for moclobemide and Body Weight
| Article | Year |
|---|---|
Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
Topics: Adult; Antidepressive Agents; Benzamides; Body Weight; Depressive Disorder; Double-Blind Method; Dru | 1994 |
Safety and efficacy during long-term treatment with moclobemide.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Blood Pressure; Body Weight; Depr | 1994 |
A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study.
Topics: Adult; Amitriptyline; Antidepressive Agents; Benzamides; Body Weight; Canada; Depressive Disorder; F | 1992 |
3 other studies available for moclobemide and Body Weight
| Article | Year |
|---|---|
[Obstructive sleep apnoea syndrome as the cause of atypical depression].
Topics: Adult; Antidepressive Agents; Body Weight; Continuous Positive Airway Pressure; Depressive Disorder; | 2011 |
Investigation of the effects of moclobemide in chronic ethanol feeding rats.
Topics: Alcohol Drinking; Animals; Benzamides; Body Weight; Central Nervous System Depressants; Ethanol; Mal | 1995 |
The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrast to iproniazid.
Topics: Animals; Benzamides; Body Weight; Chemical and Drug Induced Liver Injury; Iproniazid; Liver; Male; M | 1985 |